Nearly a year ago, Miller School of Medicine cardiologist Robert J. Myerburg, M.D., was contacted by Michael R. Rosen, M.D., a colleague at Columbia University Medical Center’s Department of Pharmacology. Rosen, a productive basic scientist with a background in cardiology, wanted to talk to his long-time friend about stem cell research.
The Miller School’s Bradley Goldstein, M.D., Ph.D., assistant professor of otolaryngology, has received a five-year, $1.1 million grant from the National Institutes of Health to study the role of stem cells in olfactory neuron regeneration. Goldstein focuses his clinical and research interests on olfactory disorders.
An international team of researchers, including Miller School pulmonologist Marilyn K. Glassberg, M.D., has confirmed the results of earlier trials that pirfenidone, a medication already approved for use in nearly three dozen countries, is effective in slowing the progress of idiopathic pulmonary fibrosis. Their findings were published in the May 20 issue of The New England Journal of Medicine.